{
"@context": "https://schema.org",
"@type": "Article",
"headline": "FDA Issues New Guidance on Biosimilar Development under the BPCIA",
"url": "https://www.lexblog.com/2019/01/11/fda-issues-new-guidance-on-biosimilar-development-under-the-bpcia/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-RS099Z08",
"url": "https://www.lexblog.com/lib/RS099Z08/"
},
"datePublished": "2019-01-11T17:00:50-05:00",
"dateModified": "2021-11-08T10:14:55-05:00",
"author": {
"@type": "Person",
"name": "Caitlin M. Wilmot"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Rothwell Figg"
},
"organizationScope": "at-publication",
"isPartOf": "Biosimilars Law Bulletin",
"about": "Food, Drug & Agriculture",
"sourceUrl": "http://www.biosimilarsip.com/?p=4761",
"sourceStability": "may-move"
}